Error message

The page you requested does not exist. For your convenience, a search was performed using the query cbssm med umich edu people andrew shuman md.

Page not found

You are here

Funded by American Cancer Society.

Funding Years: 2014-2017.

The study will examine how informal decision supporters (e.g., partners, family, and friends) contribute decisions about surgery, radiation, and chemotherapy treatment, and how these roles may vary by race and ethnicity. The project will utilize existing resources from the Cancer Surveillance and Outcomes Research Team's (CanSORT) Program Project Grant "The Challenge of Individualizing Treatments for Patients with Breast Cancer," a $13 million award received from NCI in 2012.

PI(s): Sarah Hawley

Co-I(s): Jennifer Griggs, Nancy Janz, Steven Katz, Yun Li

 

Emily Chen, MA

Research Associate

Emily Chen joined CBSSM in February 2016 and works with Drs. Julie Wright and Darin Zahuranec on several grant funded research projects on developing decision aids and family perspectives in decision making. Prior to moving to Michigan, Emily worked on several studies regarding mindfulness and cognitive styles at Harvard University. Emily received her BS in Atmospheric Science and a certificate in Neurobiology and Cognitive Science from National Taiwan University. She went on to receive her MA in Psychology from Boston University.

Last Name: 
Chen

Funded by NIH - Department of Health and Human Services

Funding Years: 1995-1999

This project was formed with the intent of giving citizens, at the grass roots level, the opportunity to help shape the kinds of policies which will govern the use of genetic technology in the future. The two principal project goals are 1.) utilizing “rational democratic deliberation” to develop recommendations for the three policy domains - laws, professional standards, and institutional policies - regarding the use and application of genome research and technology; and 2.) To disseminate the findings to the public, policymakers, health educators, and practitioners.

PI: Toby Citrin

Co-I: Edward Goldman

Funded by Kaiser Permanente Research Foundation Institute

Funding Years: 2014 - 2015.

This retrospective cohort study will assess the association of BPH treatment (5ARI and alpha-blocker medications) with the occurrence of prostate cancer related mortality. An electronic algorithm for classifying prostate cancer related deaths will be created and validated using medical records. This study will also assess a number of secondary endpoints including the occurrence of prostate cancer and metastatic prostate cancer, cardiovascular and all cause mortality.

PI(s): Sarah Hawley, Lauren Wallner (Sponsor PI)

Funded by Veterans Education Research Association of Michigan

Funding Years: 2010-2016

This research study aims to compare the effectiveness of two proven treatments for posttraumatic stress disorder (PTSD): Prolonged Exposure (PE), sertraline, and their combination. In addition, the investigators are examining predictors of response to these two treatments and how PTSD symptoms, thoughts, and biological factors may be changed by such treatments. Biological mechanisms of change are also examined including emotion processing and regulation in fMRI, HPA axis function, and genetics and genomics. The investigators are also examining acceptability of each treatment and reasons for ending treatment.

PI(s): Sheila Rauch

Co-I(s): H. Myra Kim

Funded by NIH - Department of Health and Human Services

Funding Years: 2011-2016

The MROC Study seeks to evaluate and compare from the patient's point of view the leading options for breast reconstruction after mastectomy. This study will help patients, physicians, payers and policy makers better understand the various surgeries available for breast reconstruction. Although many women choose reconstruction, the number of options as well as their pros and cons can make decision making difficult and stressful. From this research, we hope to learn more about what works best for patients undergoing these operations.

PI: Edwin Wilkins

Co-I(s): H. Myra Kim

2014 Bishop Lecture featuring Myra Christopher

Thu, May 15, 2014 (All day)
Location: 
Vandenberg Meeting Hall (2nd floor), The Michigan Hall, 911 N. University, Ann Arbor, MI.

The CBSSM Research Colloquium featured the Bishop Lecture in Bioethics as the keynote address.  Myra Christopher presented the Bishop Lecture with a talk entitled: "The Moral Imperative to Transform the Way Pain is Perceived, Judged and Treated".

Myra Christopher holds the Kathleen M. Foley Chair in Pain and Palliative Care at the Center for Practical Bioethics.  Prior to December 2011, Ms. 

Christopher was President and CEO of the Center for Practical Bioethics since its inception in 1984.  From 1998-2003, Christopher also served as the national program officer of the Robert Wood Johnson Foundation’s National Program Office for State-based Initiatives to Improve End-of Life Care which was housed at the Center.  These roles have allowed Christopher to continue her lifelong mission to improve care for those who are seriously ill and their families.

Since the late 1990s, Christopher has expanded the scope of her work to include the under treatment of chronic pain.  She is currently the Director of the Pain Action Initiative: A National Strategy (PAINS) and serves as Chair of the PAINS Steering Committee. From 2010-2011 she served as a member of Pain Study Committee at the Institute of Medicine focused on the under-treatment of pain.  In 2012 she was appointed by the Secretary of Health and Human Services, Kathleen Sibelius, to the Interagency Pain Research Coordinating Committee (IPRCC) at the National Institutes of Health. In that capacity, she also serves on the Oversight Committee for the National Pain Strategy Task Force. 

The Center for Bioethics and Social Sciences in Medicine (CBSSM) Research Colloquium was held Thursday, May 15, 2014 at the Vandenberg Meeting Hall (2nd floor), The Michigan League, 911 N. University Ave, Ann Arbor, MI 48109.

Wed, May 28, 2014

A recent study led by Dr. Sarah Hawley has found that most women who get a double mastectomy to prevent breast cancer don’t need to do it, and are often motivated by fear. Her study has been receiving national press and has been featured in NBC News, CBS News, the Chicago Tribune, MSN, and many, many other venues. Reshma Jagsi and several others were co-authors on this study.

Tanner Caverly and colleagues performed a systematic review to determine how U.S. cancer prevention and screening recommendations present the potential benefits and harms associated with the procedures. They found that 69% of recommendation statements either did not quantify benefits and harms or presented them in an asymmetric manner. They conclude that improved presentation of benefits and harms in guidelines would better ensure that clinicians and patients have access to the information required for making informed decisions.

Caverly TJ, Hayward RA, Reamer E, Zikmund-Fisher BJ, Connochie 2, Heisler M, Fagerlin A. Presentation of Benefits and Harms in US Cancer Screening and Prevention Guidelines: Systematic Review. J Natl Cancer Inst. 2016 Feb 24;108(6). pii: djv436. doi: 10.1093/jnci/djv436.
 

Research Topics: 
Wed, February 15, 2017

According to a study by Reshma Jagsi and colleagues, doctors often fail to recommend genetic testing for breast-cancer patients, even those who are at high risk for mutations linked to ovarian and other cancers. They surveyed 2,529 breast-cancer patients and found that although two-thirds of the women reported wanting genetic testing, less than a third actually got it. About 8 in 10 women at highest risk for BRCA mutations — because of family history or ancestry — said they had wanted testing, but only a little more than half received it.

Pages